Celestica director granted new RSU awards

Kale Jill reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kale Jill reported acquisition or exercise transactions in this Form 4 filing.

Celestica Inc director Jill Kale reported awards of new share-based compensation. On May 19, 2026, she received 108 restricted share units (RSUs), each representing a contingent right to one common share or equivalent cash, with one-third vesting annually over three years.

On May 20, 2026, she was granted 810 director restricted share units (D‑RSUs), which vest on the first anniversary of the grant date. These awards are compensation-related grants, not open‑market purchases or sales of Celestica common shares.

Insider Trade Summary

Grant/Award: 918 shares

Grant/Award 2 txns

Insider Kale Jill

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Restricted Share Units	810	$0.00	$0.00
Grant/Award	Restricted Share Units	108	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 108 contracts (Direct); Director Restricted Share Units — 810 contracts (Direct)

Footnotes (4)

1. F1. Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.
2. F2. On May 19, 2026, the reporting person was granted 108 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.
3. F3. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
4. F4. On May 20, 2026, the reporting person was granted 810 D-RSUs, which vest on the first anniversary of the grant date.

Key Figures

RSUs granted: 108 units Director RSUs granted: 810 units RSU vesting schedule: 1/3 annually over 3 years +2 more

5 metrics

RSUs granted 108 units Restricted share units granted on May 19, 2026

Director RSUs granted 810 units Director restricted share units granted on May 20, 2026

RSU vesting schedule 1/3 annually over 3 years 108 RSUs vest each year after May 19, 2026 grant

Director RSU vesting 100% after 1 year 810 D-RSUs vest on first anniversary of May 20, 2026 grant

Price per unit $0.00 Grant price per RSU and D-RSU in this Form 4

Key Terms

Restricted share units, Director restricted share units, contingent right, vest, +1 more

5 terms

Restricted share units financial

"On May 19, 2026, the reporting person was granted 108 RSUs, 1/3 of which vest annually"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Director restricted share units financial

"On May 20, 2026, the reporting person was granted 810 D-RSUs, which vest"

contingent right financial

"Each restricted share unit ("RSU") represents a contingent right to receive one common share"

vest financial

"1/3 of which vest annually over 3 years on the anniversary of the grant date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

equivalent value in cash financial

"represents a contingent right to receive one common share or an equivalent value in cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Celestica (CLS) director Jill Kale report?

Director Jill Kale reported receiving equity awards, not market trades. She was granted 108 restricted share units on May 19, 2026, and 810 director restricted share units on May 20, 2026, as part of her compensation package.

How many RSUs did Jill Kale receive from Celestica (CLS)?

Jill Kale received 108 restricted share units and 810 director restricted share units. The 108 RSUs vest in three equal annual installments, while the 810 director RSUs vest in full on the first anniversary of the grant date.

Are Jill Kale’s Form 4 transactions in Celestica (CLS) open-market buys or sells?

The transactions are not open‑market buys or sells. They are awards of restricted share units and director restricted share units granted at no cash cost as equity compensation, giving a contingent right to receive Celestica common shares or equivalent cash.

What are Celestica (CLS) director restricted share units (D-RSUs)?

Director restricted share units are equity awards that each represent a contingent right to receive one Celestica common share or an equivalent cash amount. For this grant, the 810 D‑RSUs vest on the first anniversary of the May 20, 2026 grant date.

How do the 108 Celestica (CLS) RSUs granted to Jill Kale vest?

The 108 restricted share units vest over three years. One‑third of the RSUs vests annually on each anniversary of the May 19, 2026 grant date, assuming continued service, providing staggered future delivery of common shares or equivalent cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 07:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kale Jill

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO ONTARIO, CANADA M2N 6L7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/19/2026		A		108		(2)	(2)	Common Shares	108	$0	108	D
Director Restricted Share Units	(3)	05/20/2026		A		810		(4)	(4)	Common Shares	810	$0	810	D

Explanation of Responses:

1. Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

2. On May 19, 2026, the reporting person was granted 108 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

3. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.

4. On May 20, 2026, the reporting person was granted 810 D-RSUs, which vest on the first anniversary of the grant date.

	/s/ Tracy Connelly McGilley, attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)